BIOFRIGAS SWEDEN AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.387 SEK | -7.64% |
|
+10.89% | -78.07% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 |
|---|---|---|---|
| Capitalization 1 | 65.63 | 115.4 | 37.88 |
| Enterprise Value (EV) 1 | 60.51 | 107.1 | 21.99 |
| P/E ratio | -13.6 x | -20.4 x | -5.53 x |
| Yield | - | - | - |
| Capitalization / Revenue | 13.4 x | 27.4 x | 19.3 x |
| EV / Revenue | 12.3 x | 25.4 x | 11.2 x |
| EV / EBITDA | -14.7 x | -19.7 x | -3.33 x |
| EV / FCF | -7,564,478 x | -12,719,888 x | -9,372,144 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 5.1 x | 5.51 x | 1.42 x |
| Nbr of stocks (in thousands) | 8,929 | 11,310 | 13,698 |
| Reference price 2 | 7.350 | 10.20 | 2.765 |
| Announcement Date | 30/03/21 | 04/04/22 | 28/04/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net sales 1 | 0.2428 | - | 4.914 | 4.218 | 1.961 |
| EBITDA 1 | -2.682 | -2.008 | -4.12 | -5.423 | -6.604 |
| EBIT 1 | -2.685 | -2.055 | -4.256 | -5.566 | -6.842 |
| Operating Margin | -1,105.5% | - | -86.62% | -131.96% | -348.92% |
| Earnings before Tax (EBT) 1 | -2.751 | -2.127 | -5.146 | -5.617 | -6.861 |
| Net income 1 | -2.751 | -2.127 | -5.146 | -5.617 | -6.861 |
| Net margin | -1,132.88% | - | -104.72% | -133.17% | -349.9% |
| EPS | - | -0.4005 | -0.5400 | -0.5000 | -0.5000 |
| Free Cash Flow | - | - | -7.999 | -8.419 | -2.346 |
| FCF margin | - | - | -162.78% | -199.6% | -119.64% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 04/06/20 | 04/06/20 | 30/03/21 | 04/04/22 | 28/04/23 |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | 0.8 | 0.79 | 5.12 | 8.27 | 15.9 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | -8 | -8.42 | -2.35 |
| ROE (net income / shareholders' equity) | - | -106% | -68.2% | -33.2% | -28.9% |
| ROA (Net income/ Total Assets) | - | -29.1% | -25.3% | -17.9% | -14.8% |
| Assets 1 | - | 7.301 | 20.35 | 31.3 | 46.4 |
| Book Value Per Share | - | 0.4200 | 1.440 | 1.850 | 1.940 |
| Cash Flow per Share | - | 0.1500 | 0.7000 | 0.8000 | 1.200 |
| Capex | - | - | - | 0.03 | 0.38 |
| Capex / Sales | - | - | - | 0.8% | 19.36% |
| Announcement Date | 04/06/20 | 04/06/20 | 30/03/21 | 04/04/22 | 28/04/23 |
1SEK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -78.07% | 539K | |
| +5.76% | 291B | |
| +1.02% | 137B | |
| +57.31% | 124B | |
| +20.71% | 81.83B | |
| +1.92% | 70.84B | |
| +3.75% | 54.93B | |
| +5.02% | 46.49B | |
| -10.79% | 35.16B | |
| +24.75% | 34.5B |
- Stock Market
- Equities
- BIOF Stock
- Financials Biofrigas Sweden AB
